Webb Joseph, Springthorpe Vicki, Rossoni Luca, Minde David-Paul, Langer Swen, Walker Heather, Alstrom-Moore Amias, Larson Tony, Lilley Kathryn, Eastham Graham, Stephens Gill, Thomas Gavin H, Kelly David J, Green Jeffrey
Molecular Biology & Biotechnology, University of Sheffield, Sheffield, United Kingdom
Department of Biology, University of York, York, United Kingdom.
mSystems. 2019 Jun 11;4(4):e00187-19. doi: 10.1128/mSystems.00187-19.
Productivity of bacterial cell factories is frequently compromised by stresses imposed by recombinant protein synthesis and carbon-to-product conversion, but little is known about these bioprocesses at a systems level. Production of the unnatural metabolite citramalate in requires the expression of a single gene coding for citramalate synthase. Multiomic analyses of a fermentation producing 25 g liter citramalate were undertaken to uncover the reasons for its productivity. Metabolite, transcript, protein, and lipid profiles of high-cell-density, fed-batch fermentations of expressing either citramalate synthase or an inactivated enzyme were similar. Both fermentations showed downregulation of flagellar genes and upregulation of chaperones IbpA and IbpB, indicating that these responses were due to recombinant protein synthesis and not citramalate production. Citramalate production did not perturb metabolite pools, except for an increased intracellular pyruvate pool. Gene expression changes in response to citramalate were limited; none of the general stress response regulons were activated. Modeling of transcription factor activities suggested that citramalate invoked a GadW-mediated acid response, and changes in GadY and RprA regulatory small RNA (sRNA) expression supported this. Although changes in membrane lipid composition were observed, none were unique to citramalate production. This systems analysis of the citramalate fermentation shows that has capacity to readily adjust to the redirection of resources toward recombinant protein and citramalate production, suggesting that it is an excellent chassis choice for manufacturing organic acids. Citramalate is an attractive biotechnology target because it is a precursor of methylmethacrylate, which is used to manufacture Perspex and other high-value products. Engineered strains are able to produce high titers of citramalate, despite having to express a foreign enzyme and tolerate the presence of a nonnative biochemical. A systems analysis of the citramalate fermentation was undertaken to uncover the reasons underpinning its productivity. This showed that readily adjusts to the redirection of metabolic resources toward recombinant protein and citramalate production and suggests that is an excellent chassis for manufacturing similar small, polar, foreign molecules.
细菌细胞工厂的生产力常常受到重组蛋白合成和碳到产物转化所施加压力的影响,但在系统层面上对这些生物过程却知之甚少。在[具体生物]中生产非天然代谢产物柠檬酸苹果酸需要表达一个编码柠檬酸苹果酸合酶的单一基因。对生产25克/升柠檬酸苹果酸的发酵过程进行了多组学分析,以揭示其生产力的原因。表达柠檬酸苹果酸合酶或失活酶的[具体生物]的高细胞密度补料分批发酵的代谢物、转录本、蛋白质和脂质谱相似。两种发酵都显示鞭毛基因下调,伴侣蛋白IbpA和IbpB上调,这表明这些反应是由于重组蛋白合成而非柠檬酸苹果酸的产生。除了细胞内丙酮酸池增加外,柠檬酸苹果酸的产生并未扰乱代谢物库。响应柠檬酸苹果酸的基因表达变化有限;没有一个一般应激反应调节子被激活。转录因子活性建模表明,柠檬酸苹果酸引发了GadW介导的酸反应,GadY和RprA调节性小RNA(sRNA)表达的变化支持了这一点。尽管观察到膜脂组成有变化,但没有一个是柠檬酸苹果酸生产所特有的。对柠檬酸苹果酸发酵的这种系统分析表明,[具体生物]有能力轻松适应资源向重组蛋白和柠檬酸苹果酸生产的重新定向,这表明它是生产有机酸的理想底盘选择。柠檬酸苹果酸是一个有吸引力的生物技术目标,因为它是甲基丙烯酸甲酯的前体,用于制造有机玻璃和其他高价值产品。工程化的[具体生物]菌株能够产生高滴度的柠檬酸苹果酸,尽管必须表达一种外源酶并耐受一种非天然生化物质的存在。对柠檬酸苹果酸发酵进行了系统分析,以揭示其生产力背后的原因。这表明[具体生物]能够轻松适应代谢资源向重组蛋白和柠檬酸苹果酸生产的重新定向,并表明[具体生物]是制造类似的小极性外源分子的理想底盘。